T.A. Dronova, N. Babyshkina, D.N. Kostromitsky, D.A. Eremin, N. Cherdyntseva
{"title":"转移性结肠癌的分子特征","authors":"T.A. Dronova, N. Babyshkina, D.N. Kostromitsky, D.A. Eremin, N. Cherdyntseva","doi":"10.18137/cardiometry.2023.29.conf.4","DOIUrl":null,"url":null,"abstract":"Metastatic colon cancer (mCC) is a heterogeneous disease, which significantly complicates its prognosis and the choice of an effective treatment strategy for patients. The use of mСС molecular profiling data will allow identifying an optimal approach to justify the choice of therapy and increase the patient’s survival rates.","PeriodicalId":41726,"journal":{"name":"Cardiometry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MOLECULAR PROFILE OF METASTATIC COLON CANCER\",\"authors\":\"T.A. Dronova, N. Babyshkina, D.N. Kostromitsky, D.A. Eremin, N. Cherdyntseva\",\"doi\":\"10.18137/cardiometry.2023.29.conf.4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Metastatic colon cancer (mCC) is a heterogeneous disease, which significantly complicates its prognosis and the choice of an effective treatment strategy for patients. The use of mСС molecular profiling data will allow identifying an optimal approach to justify the choice of therapy and increase the patient’s survival rates.\",\"PeriodicalId\":41726,\"journal\":{\"name\":\"Cardiometry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiometry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18137/cardiometry.2023.29.conf.4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiometry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18137/cardiometry.2023.29.conf.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Metastatic colon cancer (mCC) is a heterogeneous disease, which significantly complicates its prognosis and the choice of an effective treatment strategy for patients. The use of mСС molecular profiling data will allow identifying an optimal approach to justify the choice of therapy and increase the patient’s survival rates.
期刊介绍：
Cardiometry is an open access biannual electronic journal founded in 2012. It refers to medicine, particularly to cardiology, as well as oncocardiology and allied science of biophysics and medical equipment engineering. We publish mainly high quality original articles, reports, case reports, reviews and lectures in the field of the theory of cardiovascular system functioning, principles of cardiometry, its diagnostic methods, cardiovascular system therapy from the aspect of cardiometry, system and particular approaches to maintaining health, engineering peculiarities in cardiometry developing. The interdisciplinary areas of the journal are: hemodynamics, biophysics, biochemistry, metrology. The target audience of our Journal covers healthcare providers including cardiologists and general practitioners, bioengineers, biophysics, medical equipment, especially cardiology diagnostics device, developers, educators, nurses, healthcare decision-makers, people with cardiovascular diseases, cardiology and engineering universities and schools, state and private clinics. Cardiometry is aimed to provide a wide forum for exchange of information and public discussion on above scientific issues for the mentioned experts.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
